
[Federal Register Volume 78, Number 207 (Friday, October 25, 2013)]
[Notices]
[Pages 63989-63990]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-25188]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2013-N-0001]


Request for Notification From Industry Organizations Interested 
in Participating in the Selection Process for Nonvoting Industry 
Representatives and Request for Nominations for Nonvoting Industry 
Representatives on the Tobacco Products Scientific Advisory Committee

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting that 
industry organizations interested in participating in the selection of 
a nonvoting industry representative to represent the interests of the 
tobacco manufacturing industry on the Tobacco Products Scientific 
Advisory Committee for the Center for Tobacco Products, notify FDA in 
writing. A nominee may either be self-nominated or nominated by an 
organization to serve as a nonvoting industry representative. 
Nominations will be accepted for upcoming vacancy effective with this 
notice. Elsewhere in this issue of the Federal Register, FDA is 
publishing a separate document announcing the Request for Notification 
for Voting Members on the Tobacco Products Scientific Advisory 
Committee.

DATES: Any industry organization interested in participating in the 
selection of an appropriate nonvoting member to represent the interests 
of the tobacco manufacturing industry must send a letter stating the 
interest to FDA by November 25, 2013, for the vacancy listed in this 
notice. Concurrently, nomination materials for prospective candidates 
should be sent to FDA by November 25, 2013.

ADDRESSES: All letters of interest and nominations should be submitted 
in writing to TPSAC@fda.hhs.gov, or by mail to Caryn Cohen, Office of 
Science, Center for Tobacco Products, Food and Drug Administration, 
9200 Corporate Blvd., Rockville, MD 20850.

FOR FURTHER INFORMATION CONTACT: Caryn Cohen, Office of Science, Center 
for Tobacco Products, Food and Drug Administration, 9200 Corporate 
Blvd., Rockville, MD 20850,1-877-287-1373 (choose Option 5), FAX: 240-
276-3655, email: TPSAC@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: The Agency requests nominations for a 
nonvoting industry representative on the Tobacco Products Scientific 
Advisory Committee to represent the interests of the tobacco 
manufacturing industry.

I. Tobacco Products Scientific Advisory Committee

    The Tobacco Products Scientific Advisory Committee (the Committee) 
advises the Commissioner or designee in discharging responsibilities as 
they relate to the regulation of tobacco products. The Committee 
reviews and evaluates safety, dependence, and health issues relating to 
tobacco products and provides appropriate advice, information and 
recommendations to the Commissioner of Food and Drugs.
    The Committee includes three nonvoting members who represent 
industry interests. These members include one representative of the 
tobacco manufacturing industry, one representative of the interests of 
tobacco growers, and one representative of the interests of the small 
business tobacco manufacturing industry. The representative of the 
interests of the small business tobacco manufacturing industry may be 
filled on a rotating basis by representatives of different small 
business tobacco manufacturers based on areas of expertise relevant to 
the topics being considered by the Committee.
    With this notice, nominations are sought for one representative of 
the interests of the tobacco manufacturing industry, and an alternate 
to this representative.

[[Page 63990]]

II. Selection Procedure

    Any industry organization interested in participating in the 
selection of an appropriate nonvoting member to represent industry 
interests should send a letter stating that interest to the FDA contact 
(see FOR FURTHER INFORMATION CONTACT) within 30 days of publication of 
this document (see DATES). Within the subsequent 30 days, FDA will send 
a letter to each organization that has expressed an interest, attaching 
a complete list of all such organizations; and a list of all nominees 
along with their current resumes. The letter will also state that it is 
the responsibility of the interested organizations to confer with one 
another and to select a candidate, within 60 days of the receipt of the 
FDA letter, to serve as the nonvoting member to represent the tobacco 
manufacturing industry for the committee. The interested organizations 
are not bound by the list of nominees in selecting a candidate. 
However, if no individual is selected within 60 days, the Commissioner 
of Food and Drugs will select the nonvoting member to represent 
industry interests.

III. Application Procedure

    Individuals may self-nominate and/or an organization may nominate 
one or more individuals to serve as a nonvoting industry 
representative. Contact information, a current curriculum vitae, and 
the name of the committee of interest should be sent to the FDA contact 
person (see FOR FURTHER INFORMATION CONTACT) within 30 days of 
publication of this document (see DATES). FDA will forward all 
nominations to the organizations expressing interest in participating 
in the selection process for the committee. (Persons who nominate 
themselves as nonvoting industry representatives will not participate 
in the selection process).
    FDA seeks to include the views of women and men, members of all 
racial and ethnic groups, and individuals with and without disabilities 
on its advisory committees and therefore, encourages nominations of 
appropriately qualified candidates from these groups. Specifically, in 
this document, nominations for nonvoting representatives of industry 
interests are encouraged from the tobacco manufacturing industry.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: October 21, 2013.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2013-25188 Filed 10-24-13; 8:45 am]
BILLING CODE 4160-01-P


